Abel Hall LLC’s Axcelis ACLS Stock Holding History

Abel Hall LLC’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$497K	Buy	2,622 +5	+0.2%	+$742	0.09%	245
2026 Q1	$244K	Sell	2,617 -12	-0.5%	-$1.06K	0.05%	510
2025 Q4	$211K	Buy	+2,629	New	+$220K	0.05%	514

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Abel Hall LLC's ACLS Position: Q2 2026 in Review

Abel Hall LLC increased its Axcelis (ACLS) stake by 0.19% in Q2 2026, buying an estimated $742 and bringing the position to 2,622 shares worth $497K. The position accounts for 0.09% of the portfolio, ranked #245.

Abel Hall LLC first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Abel Hall LLC held 2,622 shares of Axcelis worth $497K as of Q2 2026.
Abel Hall LLC bought 5 Axcelis shares in Q2 2026, an estimated $742.
Axcelis made up 0.09% of Abel Hall LLC's portfolio in Q2 2026, its #245 holding.
Abel Hall LLC first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.